Clinical Trial

TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)

Name: TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) — clinical trial record (NCT07355257)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the efficacy of Telitacicept in the treatment of inflammatory myopathy in patients with inflammatory diseases. The main question it aims to answer is: the safety and effectiveness of Telitacicept in treating inflammatory myopathy.

Trial Details

NCT Number	NCT07355257
Lead Sponsor	Zhongming Qiu
Conditions	Inflammatory Myopathy
Enrollment	30 participants
Start Date	2026-02-02
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-21